Publications en collaboration avec des chercheurs de Universidad de Salamanca (51)

2024

  1. Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia

    Biomarker Research

2023

  1. NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia

    Free Radical Biology and Medicine, Vol. 198, pp. 92-108

  2. NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival

    Free Radical Biology and Medicine, Vol. 209, pp. 18-28

2022

  1. A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival

    American Journal of Hematology, Vol. 97, Núm. 4, pp. 448-457

  2. Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia

    Leukemia, Vol. 36, Núm. 8, pp. 2132-2135

  3. Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison

    Frontiers in immunology, Vol. 13, pp. 889875

2021

  1. Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins

    Haematologica, Vol. 106, Núm. 1, pp. 142-153

  2. Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  3. Nucleoredoxin Downregulation Reduces β-Catenin Levels and Shifts Hematopoietic Differentiation towards Myeloid Lineage In Vitro

    BioChem, Vol. 1, Núm. 1, pp. 26-35

2020

  1. Inhibition of xanthine oxidoreductase enhances the potential of tyrosine kinase inhibitors against chronic myeloid leukemia

    Antioxidants, Vol. 9, Núm. 1

2019

  1. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  2. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: An alternative approach against acute myeloid leukemia

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2018

  1. Reactive oxygen species in haematopoiesis: Leukaemic cells take a walk on the wild side

    Journal of Experimental and Clinical Cancer Research, Vol. 37, Núm. 1

2017

  1. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?

    Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202

  2. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

    PLoS ONE, Vol. 12, Núm. 8

  3. The importance of NADPH oxidases and redox signaling in angiogenesis

    Antioxidants, Vol. 6, Núm. 2

2016

  1. ARMS/Kidins220 and synembryn-B levels regulate NGF-mediated secretion

    Journal of Cell Science, Vol. 129, Núm. 9, pp. 1866-1877

  2. Changes in the expression of LIMP-2 during cerulein-induced pancreatitis in rats: Effect of inhibition of leukocyte infiltration, cAMP and MAPKs early on in its development

    International Journal of Biochemistry and Cell Biology, Vol. 72, pp. 109-117

  3. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry

    Cell Communication and Signaling, Vol. 14, Núm. 1

  4. The DARC-CD82 axis discloses bone marrow macrophages as guardians of long-term hematopoietic stem cells quiescence

    Stem Cell Investigation